Inhaler Adapter Flow Rate Indicator for pMDI Coordination
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Patients frequently misuse pressurized metered dose inhaler (pMDI) devices by failing to coordinate inhalation with actuation, leading to sub-optimal drug delivery, with 85.6% of users tested incorrectly using their devices, resulting in inadequate drug administration for conditions like asthma.
Innovation Solution
An adapter with an air flow rate indicator that provides an audible or visual signal when the inhalation rate reaches a predetermined minimum, ensuring proper air flow for effective drug delivery, integrated into existing pMDI devices to guide patients in using the device correctly.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If patients use pMDI devices without training or feedback mechanisms, then the device structure remains simple, but patient compliance and correct usage rate deteriorates (85.6% failure rate)
Solution Approach 1:
The patent incorporates visual and audible feedback mechanisms that provide real-time information to patients about their inhalation rate and coordination with device actuation. The visual indicator shows whether inhalation rate is within the optimal range, while the audible signal confirms proper coordination between inhalation and drug delivery, enabling patients to self-correct their technique and improve compliance
Solution Approach 2:
The patent introduces a feedback mechanism as an intermediary between the patient and the drug delivery process. This intermediary provides translated information about inhalation parameters in an easily understandable format (visual indicators and audible signals), bridging the gap between complex physiological actions and patient comprehension
2Productivity
If patients inhale too quickly, then the air flow rate increases, but drug delivery efficacy deteriorates due to poor coordination and premature inhalation
Solution Approach 1:
The visual indicator provides real-time feedback on whether the inhalation rate is within the optimal range (10-30 L/min). By showing whether the rate is too low, too high, or optimal, patients can adjust their inhalation speed to match the drug delivery process, ensuring they inhale at the right rate at the right time to maximize drug uptake
Solution Approach 2:
The feedback mechanism alerts patients in advance whether their inhalation rate is appropriate before they complete the full inhalation act. This preliminary feedback allows patients to adjust their inhalation rate during the act itself, ensuring optimal conditions for drug delivery rather than only providing feedback after the fact
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The air flow rate indicator ensures that patients inhale at an optimal rate, enhancing the delivery of aerosolized drugs to the lungs, improving treatment efficacy and compliance by providing real-time feedback on correct usage.
Implementation Method 1
an air flow rate indicator operable to indicate when the air flow rate along the air flow path is at or above a predetermined minimum level suitable for delivery of the drug to the patient
Data Source
AI summary
An adapter for fitting to a drug delivery device, the adapter including: an outlet for communication with the mouth of a patient; an air flow path through the adapter along which air is drawn to the outlet by inhalation by the patient; an inlet adapted for connection to a mouthpiece of the drug delivery device; and an air flow rate indicator operable to indicate when the air flow rate along the air flow path is at or above a predetermined minimum level suitable for delivery of the drug to the patient. A drug delivery device having, in its body, an air flow rate indicator operable to indicate when the air flow rate along the air flow path is at or above a predetermined minimum level suitable for delivery of the drug to the patient.